Page last updated: 2024-08-25

bendamustine hydrochloride and ixazomib

bendamustine hydrochloride has been researched along with ixazomib in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Ballestrero, A; Calabrese, M; Ceccardi, A; Cuccarolo, P; Dameri, M; Garlaschi, A; Gristina, L; Stabile, M; Tagliafico, A; Valente, I; Zoppoli, G1
Adam, Z; Boichuk, I; Král, Z; Krejčí, M; Pour, L; Sandecká, V; Štork, M; Zeman, D1

Reviews

1 review(s) available for bendamustine hydrochloride and ixazomib

ArticleYear
Waldenström's macroglobulinemia - clinical symptoms and review of therapy yesterday, today and tomorrow.
    Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2023,Spring, Volume: 36, Issue:3

    Topics: Antibodies, Monoclonal; Antineoplastic Agents; Bendamustine Hydrochloride; Cyclophosphamide; Humans; Proteasome Inhibitors; Rituximab; Waldenstrom Macroglobulinemia

2023

Other Studies

1 other study(ies) available for bendamustine hydrochloride and ixazomib

ArticleYear
Complete pathological response of hormone receptor positive invasive breast cancer in a patient with multiple myeloma treated with ixazomib.
    Tumori, 2023, Volume: 109, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Breast Neoplasms; Dexamethasone; Female; Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Recurrence

2023